Table 2:
(A) Ocular complications in non-ocular surgery, risk factors, prevention, and treatment. (B) Commonly encountered ocular conditions, pre- and intra-operative concerns, what is known/not known in relation to anesthesia, and management recommendations. See text for more details and references. Due to space constraints, not all conditions are shown.
A | Exposure keratopathy | Loss of eye contents | Acute angle closure glaucoma | Ischemic optic neuropathy | Central retinal artery occlusion |
---|---|---|---|---|---|
Risk Factors | *General anesthesia *Decreased tear production *Patient positioning *Abnormal eyelid closure |
*Corneal transplant *Open globe injury |
*History of glaucoma *Genetics *Female *Elderly *Anatomical factors *Asian race |
*Spine fusion *Cardiac surgery *Head and neck *For spine surgery: Prone positioning, large estimated blood losses, lower colloid compared to crystalloid fluid administration, lengthier anesthesia duration, Wilson frame use, obesity, and male sex |
*Spine fusion *Cardiac surgery *Head and neck *Use of N2O with recent vitrectomy and gas bubble *For spine surgery: compression of the eye *For cardiac surgery: emoblism from heart or aorta |
Prevention | *Completely cover the eyes after induction of anesthesia *Use of ointments in some cases *Remove contact lenses *Protect eye from false eyelashes |
*Protect eyes from trauma/increased IOP *Eye shield, caution during positioning of patient |
*Medications to avoid in susceptible individuals (see text): para-sympatholytic or sympathomimetic drugs | No established strategy but see text for ASA Task Force on Perioperative Visual Loss recommendations | *Headrests and care to prevent eye compression in spine surgery with patient prone *Decrease embolic phenomena in heart surgery *Avoid N2O when vitreous gas bubble present (see text) |
Treatment | *Analgesia (local anesthetic eye drops not advisable) *Antibiotics/eye cover in some cases *Treatment/followup by an ophthalmologist |
*None. Prevention is paramount to avoid profound visual loss | * Immediate reduction of IOP by medications AND *Peripheral iridectomy *Treatment/followup by an ophthalmologist |
*Increase blood pressure and hemoglobin levels *Elevate the head *Steroids *Hyperbaric oxygen None of these are proven effective. In all cases, consultation on treatment with neuro-ophthalmologist |
*Thrombolysis, but may be risky in post-operative patient. *Consultation on treatment with neuro-ophthalmologist |
B | Idiopathic intracranial hypertension | Glaucoma | Low vision |
---|---|---|---|
Pre-op eye concerns | *Optic nerve disease: double vision, loss of vision, optic nerve swelling | *Visual field loss, low vision, increased intraocular pressure | *Difficulty with consent *Communication issues *Altered mood, alertness |
Intra-operative concerns | *Spinal and epidural analgesia *Caution in COPD patients on acetazolamide |
*Head down or prone positioning and visual outcomes | *None |
What is known | *Both spinal and epidural may be used safely *Continue pre-operative medications for the disease |
*Intraocular pressure increased by positioning prone or head down | *Many causes including glaucoma, diabetic retinopathy, macular degeneration, congenital |
What is not known/Perioperative management recommendations | *Impact of further increases in intraocular pressure on vision after surgery/positioning prone or head down is not known *Advisable to keep systemic blood pressure at or near patient’s baseline, as systemic blood pressure is a major influence on ocular perfusion pressure; evidence base still lacking. *Continue the patient’s pre-operative eye drops up until time of surgery |
*The impact of low vision with or without altered alertness on awakening after anesthesia is not known. *Anticipate the need for more time to obtain a pre-operative anesthesia consent. |
Abbreviations: ASA = American Society of Anesthesiologists. COPD = chronic obstructive pulmonary disease. IOP = intraocular pressure. N2O = nitrous oxide